Related Experiment Video
Updated: Jun 16, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
Predicting Cognitive Decline in Motoric Cognitive Risk Syndrome Using Machine Learning Approaches
Jin-Siang Shaw1, Ming-Xuan Xu1, Fang-Yu Cheng2
1Institute of Mechatronic Engineering, National Taipei University of Technology, Taipei 106, Taiwan.
Diagnostics (Basel, Switzerland)
|June 13, 2025
Summary
Predicting cognitive decline in Motoric Cognitive Risk Syndrome (MCR) is possible using machine learning. Combining biomarkers, gait, and cognitive tests accurately identifies individuals at risk for future cognitive deterioration.
Area of Science:
- Neuroscience
- Gerontology
- Biostatistics
Background:
- Motoric Cognitive Risk Syndrome (MCR) signifies a preclinical state for cognitive decline.
- Early prediction of cognitive deterioration in MCR is crucial due to variable progression.
- Identifying individuals with MCR who will progress is essential for timely intervention.
Purpose of the Study:
- To develop and validate a machine learning model for predicting short-term cognitive decline in MCR.
- To identify key predictors of cognitive decline in individuals with MCR.
- To assess the feasibility of integrating multimodal data for predictive modeling.
Main Methods:
- Utilized Support Vector Machine (SVM) classifiers to predict cognitive decline in 80 MCR participants (≥60 years).
- Baseline assessments included plasma biomarkers (β-amyloid, tau), dual-task gait, and neuropsychological tests.
- Models were trained and validated using feature importance analysis and cross-validation.
Main Results:
- Plasma β-amyloid and tau, dual-task gait, and memory scores were significant predictors of cognitive decline.
- The optimal linear SVM model achieved 88.2% accuracy and 83.7% AUC on the test set.
- Cross-validation demonstrated high performance with 95.3% average accuracy and 99.6% AUC.
Conclusions:
- Machine learning effectively integrates biomarker, motor, and cognitive data to predict cognitive decline in MCR.
- The developed model shows potential for clinical application in identifying at-risk individuals.
- External validation is recommended to confirm the generalizability and robustness of the predictive model.

